Safe, Effective Prescription Mental Wellness. For Everyone.
Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky, Compared to existing psychedelics, our gentler, less euphoric compounds can facilitate psychotherapy, decision-making, and psychological growth while having less need for the expensive clinical monitoring. Our IP includes drug discovery methods, novel molecules, and pharmaceutical preparations. These all focus on one goal: enabling safer take-home prescription empathogens. We believe this will be the key to effective and accessible mental wellness. Tactogen: Effective Prescription Mental Wellness. For Everyone.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 3790 El Camino Real,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tactogen.com
- Keywords
- pharmaceuticals, empathogens, drug discovery, machine learning, artificial intelligence, small molecules, intellectual property, public benefit corporation, mental health.
- HQ
- Palo Alto, CA
Tactogen Questions
Tactogen's website is tactogen.com
Tactogen's LinkedIn profile is https://www.linkedin.com/company/tactogen
Tactogen has
4 employees.
View email and phone details for 4
employees at Tactogen.
Tactogen's industry is
Biotechnology Research
Tactogen's top competitors are
Cybin Inc,
Beckley Psytech,
Gilgamesh Pharmaceuticals,
Sensorium Therapeutics,
Usona Institute,
Compass Pathways,
Mindmed,
Atai Life Sciences,
Lykos Therapeutics,
Delix Therapeutics.
Tactogen's categories are Biotechnology Research
Tactogen's founding year is 2020
